INFLIXIMAB AND EMERGING BIOLOGICAL TREATMENT FOR PEDIATRIC CROHN’S DISEASE. EuroMediterranean Biomedical Journal, [S. l.], v. 4, 2026. DOI: 10.4081/embj.2009.536. Disponível em: https://www.embj.org/home/article/view/536. Acesso em: 29 apr. 2026.